MedPath
NMPA Approval

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)

国药准字H20253378

February 11, 2025

Drug Information

达格列净二甲双胍缓释片(Ⅲ)

片剂

每片含达格列净5mg(按C₂₁H₂₅ClO₆计)和盐酸二甲双胍1000mg

化学药品

February 11, 2025

Company Information

Applicant Company

山东省济南市高新区新泺大街317号

Manufacturing Company

山东省济南市高新区旅游路8888号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达格列净二甲双胍缓释片(Ⅲ) - NMPA 批准文号 | MedPath